Iradimed Corp. (IRMD) Tops Q2 EPS by 5c

Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.49, $0.05 better than the analyst estimate of $0.44. Revenue for the quarter came in at $20.4 million versus the consensus estimate of $20.01 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• U.S. presses Meta to agree to A.I. reviews as security concerns rise - NYT